600201.SH
生物股份
SSE · Healthcare · Biotechnology · CN
CNY 12.43
−1.74%Margins
Gross margin
53.3%
EBITDA margin
26.1%
EBIT margin
7.6%
Net margin
7.5%
FCF margin
11.2%
1.9%
Return on equity
1.6%
Return on assets
1.9%
Return on invested capital
0.21x
Asset turnover
CNY 301.3M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026